Investing.com - Volitionrx Ltd (NYSE: VNRX) reported second quarter EPS of $-0.080, $0.01 better than the analyst estimate of $-0.094. Revenue for the quarter came in at $395.8K versus the consensus estimate of $462.98K.
Volitionrx Ltd's stock price closed at $0.55. It is down -28.310% in the last 3 months and down -53.610% in the last 12 months.
Volitionrx Ltd saw 1 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Volitionrx Ltd's stock price’s past reactions to earnings here.
According to InvestingPro, Volitionrx Ltd's Financial Health score is "weak performance".
Check out Volitionrx Ltd's recent earnings performance, and Volitionrx Ltd's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar